Bexion Pharmaceuticals, Inc. Announces Completion Of Enrollment In Open Label Portion Of ...
The ASIST study will assess the safety and efficacy of BXQ-350 plus SOC, modified FOLFOX7 (mFOLFOX7) and bevacizumab, in patients with newly diagnosed mCRC. The study is also evaluating whether the ...
Intellia Therapeutics: Buy Rating Driven by Promising Efficacy and Safety of Nex-Z Treatment
JonesTrading analyst Debanjana Chatterjee has reiterated their bullish stance on NTLA stock, giving a Buy rating on November 13. Debanjana ...
Nottingham Post2 天
Common nighttime habit could be 'red flag' sign of diabetes
An expert has flagged the common signs of diabetes, including a common nighttime habit. As World Diabetes Day was marked on ...
MedPage Today2 天
Response Duration After Stopping Enfortumab Vedotin in Bladder Cancer
And these data are really quite interesting and impressive that if you don't progress and that your time on [enfortumab ...
Knowridge3 天
New light therapy offers hope for diabetic nerve pain relief
A recent study from the Federal University of São Paulo (UNIFESP) has found that using infrared light along with regular ...
Pioneering surgical approach set to pave the way for hearing loss treatment
University of Sheffield spinout company, Rinri Therapeutics, a company focused on developing new treatments for hearing loss ...
Light-based therapy reduces pain associated with peripheral diabetic neuropathy, study ...
A study conducted at the Federal University of São Paulo (UNIFESP) in Brazil has concluded that the use of monochromatic ...
MedPage Today5 天
Electronic Symptom Screening in Kids With Cancer Boosts Quality of Care
Symptom screening improved symptom scores among children with cancer compared with usual care, two randomized trials showed.